Wide Ranks

ERNA

Eterna Therapeutics Inc.

0.4400

Top Statistics
Market Cap 22 M Forward PE -0.0458 Revenue Growth 0.00 %
Current Ratio 0.37 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -2.37 Enterprise / Revenue 319.17 Price To Sales Trailing12 Months 139.54
Profitability
Profit Margins 0.00 % Operating Margins -10491.49 %
Balance Sheet
Total Cash 2 M Total Cash Per Share 0.4780 Total Debt 49 M
Total Debt To Equity Current Ratio 0.37 Book Value Per Share 0.4130
All Measures
Short Ratio 107.00 % Message Board Id finmb_24349026 Shares Short Prior Month 54421
City Cambridge Uuid 280db8c6-d665-3e8c-aebc-b7fe5ee139e0 Previous Close 0.4681
First Trade Date Epoch Utc 683 M Book Value 0.4130 Beta 7.77
Total Debt 49 M Volume 183521 Price To Book 1.07
Last Split Date 1 B Fifty Two Week Low 0.4300 Total Cash Per Share 0.4780
Total Revenue 162000 Shares Short Previous Month Date 1 B Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins -10491.49 % Net Income To Common -23936000
Short Percent Of Float 0.0009 Implied Shares Outstanding 51 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 391490 Average Volume10days 391490
Total Cash 2 M Next Fiscal Year End 1 B Revenue Per Share 0.0300
Held Percent Insiders 3.36 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 0.4681 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.9798 Open 0.5000
Free Cashflow -11775750 State MA Dividend Yield 0.00 %
Return On Assets -0.2942 Time Zone Short Name EST Trailing Eps -8.31
Day Low 0.4339 Address1 1035 Cambridge Street Shares Outstanding 51 M
Price Hint 4 Target High Price 0.0000 Website https://eternatx.com
52 Week Change -0.5111 Average Volume 93540 Forward Eps -9.60
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 29.30 %
Last Split Factor 1:20 Regular Market Day High 0.5000 Is_sp_500 False
Profit Margins 0.00 % Fifty Two Week High 2.63 Day High 0.5000
Shares Short 44458 Regular Market Open 0.5000 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 319.17 Revenue Growth 0.00 %
Shares Percent Shares Out 0.0009 Operating Cashflow -16493000 Currency USD
Time Zone Full Name America/New_York Market Cap 22 M Is_nasdaq_100 False
Zip 02141 Quote Type EQUITY Industry Biotechnology
Long Name Eterna Therapeutics Inc. Regular Market Day Low 0.4339 Held Percent Institutions 0.1100
Current Price 0.4400 Address2 Suite 18A Enterprise To Ebitda -2.37
Financial Currency USD Current Ratio 0.37 Gross Margins -111.11 %
Industry Disp Biotechnology Country United States Float Shares 3 M
Two Hundred Day Average 1.68 Ir Website http://www.buzztime.com/investor-relations.html Enterprise Value 51 M
Price To Sales Trailing12 Months 139.54 Forward PE -0.0458 Regular Market Volume 183521
Ebitda -21863000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies.

Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system.

The company has a license agreement with Factor Bioscience Limited.

Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.